CN Patent

CN101535276B — 作为ALK和c-MET抑制剂的2,4-二氨基嘧啶稠合双环衍生物

Assigned to Cephalon LLC · Expires 2013-08-28 · 13y expired

What this patent protects

本发明提供了式I或II的化合物 或其药学上可接受的盐形式，其中R 1 、R 2 、R 3 、R 4 、R 5 、A 1 、A 2 、A 3 、A 4 和A 5 ，如本文所限定。式I或II的化合物具有ALK和/或c-Met抑制活性，且可以用于治疗增生性疾病。

USPTO Abstract

本发明提供了式I或II的化合物 或其药学上可接受的盐形式，其中R 1 、R 2 、R 3 、R 4 、R 5 、A 1 、A 2 、A 3 、A 4 和A 5 ，如本文所限定。式I或II的化合物具有ALK和/或c-Met抑制活性，且可以用于治疗增生性疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN101535276B
Jurisdiction
CN
Classification
—
Expires
2013-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Cephalon LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.